MedPath

ACP for Local Application in Ankle Arthrodesis

Not Applicable
Terminated
Conditions
Ankle Arthritis
Interventions
Biological: Autologous Concentrated Plasma
Registration Number
NCT01131455
Lead Sponsor
Columbia Orthopaedic Group, LLP
Brief Summary

To compare the outcomes of patients who undergo three different types of surgeries for ankle fusion and reconstruction.

Detailed Description

It is understood that an elevated concentration of platelets in the mix of the arthrodesis construct applied intra-operatively to the bony surface, has osteo-generating and enhanced wound healing properties. With that knowledge there is a clinical need and enthusiasm for the application of concentrated platelets, which release a large quantity of growth factors to encourage recovery in non healing injuries or surgical sites. This study represents an effort to more clearly define the true clinical outcomes with or without biologic enhancement, and fulfills a need for fortifying evidence concerning the efficacy of ACP in live human bone healing-- based on radiographic and CT scans.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • patients whom present the need for the elective surgery
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fusion+ACP+AutograftAutologous Concentrated PlasmaStandard anatomic reduction will be adhered to- neutral alignment will be employed (5° valgus, external rotation and neutral foot dorsiflexion). The arthrodesis undertaken for all groups will be the standard arthroscopic ankle arthrodesis with portals to the ankle (anterior medial / anterior lateral), skin incision only technique with dissection through the capsule and penetration to the joint. Standard debridement of the gutters, tibia osteophyte, tibia-talor joint resection and autograft preparation will be performed in the joint. Depending on randomization of the subject, (Autologous concentrated Plasma)ACP-A or ACP-DBM mixture will be added to the arthrodesis site with the joint taken through range of direct motion and reduced.
Fusion + ACP +DBMAutologous Concentrated PlasmaStandard anatomic reduction will be adhered to- neutral alignment will be employed (5° valgus and external rotation and neutral foot dorsiflexion). Depending on the randomization of the subject, (Autologous Concentrated Plasma)ACP-A or ACP-DBM mixture will be added to the arthrodesis site with the joint taken through range of direct motion and then reduced.
Primary Outcome Measures
NameTimeMethod
CT Scan for Fusion Analysis8 weeks post op.

There will be no outcome analysis for the CT scan performed on the 10 patients due to the death of the primary investigator.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Columbia Orthopedic Group

🇺🇸

Columbia, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath